Puretech Health Share Discussion Threads

[rambutan2] 09/6/2017 14:11

Is worth remembering that PRTC offers effectively 100% $US exposure.

[rambutan2] 09/6/2017 14:08

Jefferies webcast now available:

[lendmeafiver] 01/6/2017 14:28

I sat through the Webcast of the investor meeting in London last month, he pitched in at the end, exit strategy, sounded good, clearly a highly experienced sector chap.

[rambutan2] 01/6/2017 12:43

Agree. And as chance would have it, there's an opportunity to listen to him present a week today:

PureTech Health to Present at Jefferies 2017 Global Healthcare Conference

PureTech Health plc ("PureTech", LSE: PRTC), an advanced, clinical-stage biopharmaceutical company, today announced that Bharatt Chowrira, President and Chief of Business and Strategy at PureTech Health, will present at the Jefferies 2017 Global Healthcare Conference in New York City on Thursday, 8 June, at 9.30AM EDT. A webcast of the presentation will be available at under the Reports and Presentations tab.

[lendmeafiver] 01/6/2017 09:26

Yes he certainly likes what he has on his hands here, I think given his job is effectively the end deal making and value creation his purchases are particularly important.

[rambutan2] 01/6/2017 03:42

Having only joined the company at the start of March, Mr Chawrira continues in his share buying spree with another 30k yesterday. Since his initial purchase on April 6, he's accumulated 391,460 at prices between 114p-120p. And this is despite, on April 13, being awarded 1.2m options (various conditions attached) exercisable at 114.25p. And on May 23 being awarded up to 1.015m performance related shares, exercisable at just 1p after 2020. So, he's clearly keen to quickly get some skin in the game, and not just wait and see whether the options are worth exercising in a few year's time.

[rambutan2] 26/5/2017 03:26

All 5 of the brokers (Jefferies, Numis, Liberum, N1 and Peel) that follow PRTC have them as a buy and recent price targets ranging from 248p to 258p ie 100% upside from current price. Is this a case of very optimistic group think? Or is Mr Mkt missing the obvious?

[rambutan2] 26/5/2017 03:14

Noted that IPO are bidding for IVO, and yet again raising money to fund themselves.

[nimbo1] 23/5/2017 15:35

looking firmer today : )

[rambutan2] 22/5/2017 03:50

Hi PUGUGLY, yes i too am not a fan of the likes of IVO, IPO and wouldn't touch ALD with a bargepole. The former two have been around for a long time now and generated no cash, just raised loads from the likes of Woodford. I think PRTC looks a much more interesting proposition. It's focussed on one sector, has a handfull of not so early stage big bets, a very heavyweight board, management and set of scientific advisors. And enough cash for at least another two years. Both Akili and Gelesis will report key studies in the next few months and if either gets the thumbs up, then PRTC will rerate from its current price. Yes it is risky, but that is the sector for you, at least with PRTC you have a basket of bets, backed by cash and the very best know how.

[pugugly] 21/5/2017 19:16

Rambutan2: There are also many cases of apparent incubator (VC and VC Style) failures in this area possibly the most notorious at the moment is Allied Minds a Patient Capital Trust holding- You pays your money to see - as they say in poker.

[rambutan2] 21/5/2017 18:10

Karuna is progressing a potential blockbuster:

[rambutan2] 19/5/2017 03:49

Gelesis key trial results are due out "mid 2017". If a success, then appears an ipo could well be the way to go:

[rambutan2] 19/5/2017 03:26

Webcast of last week's capital markets day is now available and well worth a watch/listen:

[rambutan2] 19/5/2017 03:23

The above PRTC valuation didn't include resTORbio, which will certainly be included in the growth stage holdings at the next valuation:





A drug derived from an Easter Island bacterium extends the life of lab animals. People could be next...

[rambutan2] 13/5/2017 03:37

Recently joined the throng. Intended as a long term hold. Lots to like, including plenty of cash.

Out of interest, other broadly similar listed incubator style cos, and most recent valuation. Whilst the first three all trade at premiums, PRTC trades at a 30% discount.

IVO: 293p (net assets of £472m, including £113m cash) as at 31 Jan interims.
Shares price was offered at 308p at close today.


IPO: 127p (At 30 April 2017, the Group had cash of £93m, a diversified portfolio valued at £652m and net assets of £797m. The Group's 'Hard' net assets, i.e. excluding goodwill and intangibles, were £720m or approximately 127p per share.)
Share price was offered at 144p at close today.


SYNC: 136p as at 31 March ( )
Share price was offered at 150p at close today.


PRTC: 186p (PureTech Health's Asset Value (Corporate Cash + Growth-Stage Holdings Value ie $192m + $380m) at 31 December 2016 is $572 million (£443m). This Asset Value does not include 15 project and concept stage programmes that are not yet formally valued by the Group.)
Share price was offered at 120p at close today.

[lendmeafiver] 13/5/2017 01:08

It's just good to know I'm not alone here, stick with this nervousnovice I think this company is a multi billion market map in the making. Lets enjoy the ride.

[nervousnovice] 13/5/2017 00:38

ha ha one share trade - I can only assume it was brokers management costs. At least it was followed by a substantive buy £184k. Looks like we are moving up at last. Resistance is at 120 so a close above that would likely see a swift move up to 140.

[lendmeafiver] 12/5/2017 15:51

Hitting the 120 level at last

[lendmeafiver] 12/5/2017 00:42

What's with the late 1 share trade, bit odd.

[lendmeafiver] 11/5/2017 10:02

One more decent sized buy and this will breach 120+

[lendmeafiver] 11/5/2017 09:14

Certainly looking like it's heading north now. Hopefully the company will put a webcast up on this weeks capital markets meeting.

[nervousnovice] 10/5/2017 17:09

Highest close since January lets hope this is not another false dawn and we get a close above the resistance line tomorrow.So close to it tonight.

[nervousnovice] 09/5/2017 09:50

yeah good purchase, there is not a great deal of trading in this share generally. A break though on any of their products could send it rocketing, lets hope that comes sooner rather than later. It looks like the bottom as in at 110 but progress on the share price has been painfully slow.

[lendmeafiver] 09/5/2017 09:24

Nice 309k purchase this morning